AAAAAA
Results: 1-25/51
Authors:
Yamashita, N
Baxter, GF
Yellon, DM
Citation: N. Yamashita et al., Exercise directly enhances myocardial tolerance to ischaemia-reperfusion injury in the rat through a protein kinase C mediated mechanism, HEART, 85(3), 2001, pp. 331-336
Authors:
Jaberansari, MT
Baxter, GF
Muller, CA
Latouf, SE
Roth, E
Opie, LH
Yellon, DM
Citation: Mt. Jaberansari et al., Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium, J AM COL C, 37(7), 2001, pp. 1996-2001
Authors:
Schulman, D
Latchman, DS
Yellon, DM
Citation: D. Schulman et al., Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury, AM J P-HEAR, 281(4), 2001, pp. H1630-H1636
Authors:
Ebrahim, Z
Yellon, DM
Baxter, GF
Citation: Z. Ebrahim et al., Bradykinin elicits "second window" myocardial protection in rat heart through an NO-dependent mechanism, AM J P-HEAR, 281(3), 2001, pp. H1458-H1464
Authors:
Baxter, GF
Mocanu, MM
Brar, BK
Latchman, DS
Yellon, DM
Citation: Gf. Baxter et al., Cardioprotective effects of transforming growth factor-beta 1 during earlyreoxygenation or reperfusion are mediated by p42/p44 MAPK, J CARDIO PH, 38(6), 2001, pp. 930-939
Authors:
Dana, A
Baxter, GF
Yellon, DM
Citation: A. Dana et al., Delayed or second window preconditioning induced by adenosine al receptor activation is independent of early generation of nitric oxide or late induction of inducible nitric oxide synthase, J CARDIO PH, 38(2), 2001, pp. 278-287
Authors:
Minners, J
Lacerda, L
McCarthy, J
Meiring, JJ
Yellon, DM
Sack, MN
Citation: J. Minners et al., Ischemic and pharmacological preconditioning in Girardi cells and C2C12 myotubes induce mitochondrial uncoupling, CIRCUL RES, 89(9), 2001, pp. 787-792
Authors:
Mocanu, MM
Maddock, HL
Baxter, GF
Lawrence, CL
Standen, NB
Yellon, DM
Citation: Mm. Mocanu et al., Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide, CIRCULATION, 103(25), 2001, pp. 3111-3116
Authors:
Carroll, R
Gant, VA
Yellon, DM
Citation: R. Carroll et al., Mitochondrial K-ATP channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation, CARDIO RES, 51(4), 2001, pp. 691-700
Authors:
Brar, BK
Stephanou, A
Liao, ZH
O'Leary, RM
Pennica, D
Yellon, DM
Latchman, DS
Citation: Bk. Brar et al., Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation, CARDIO RES, 51(2), 2001, pp. 265-274
Authors:
Kevelaitis, E
Patel, AP
Oubenaissa, A
Peynet, J
Mouas, C
Yellon, DM
Menasche, P
Citation: E. Kevelaitis et al., Backtable heat-enhanced preconditioning: A simple and effective means of improving function of heart transplants, ANN THORAC, 72(1), 2001, pp. 107-112
Authors:
Bell, RM
Yellon, DM
Citation: Rm. Bell et Dm. Yellon, Preconditioning: what is its potential?, CHALLENGES IN ACUTE CORONARY SYNDROMES, 2001, pp. 234-252
Authors:
Rubino, A
Yellon, DM
Citation: A. Rubino et Dm. Yellon, Ischaemic preconditioning of the vasculature: an overlooked phenomenon forprotecting the heart, TRENDS PHAR, 21(6), 2000, pp. 225-230
Authors:
Yellon, DM
Baxter, GF
Citation: Dm. Yellon et Gf. Baxter, Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?, HEART, 83(4), 2000, pp. 381-387
Authors:
Baxter, GF
Hale, SL
Miki, T
Kloner, RA
Cohen, MV
Downey, JM
Yellon, DM
Citation: Gf. Baxter et al., Adenosine A(1) agonist at reperfusion trial (AART): Results of a three-center, blinded, randomized, controlled experimental infarct study, CARDIO DRUG, 14(6), 2000, pp. 607-614
Authors:
Joyeux, M
Arnaud, C
Richard, MJ
Yellon, DM
Demenge, P
Ribuot, C
Citation: M. Joyeux et al., Effect of okadaic acid, a protein phosphatase inhibitor on heat stress-induced HSP72 synthesis and thermotolerance, CARDIO DRUG, 14(4), 2000, pp. 441-446
Authors:
Joyeux, M
Boumendjel, A
Carroll, R
Ribuot, C
Godin-Ribuot, D
Yellon, DM
Citation: M. Joyeux et al., SB 203580, a mitogen-activated protein kinase inhibitor, abolishes resistance to myocardial infarction induced by heat stress, CARDIO DRUG, 14(3), 2000, pp. 337-343
Authors:
Sack, MN
Harrington, LS
Jonassen, AK
Mjos, OD
Yellon, DM
Citation: Mn. Sack et al., Coordinate regulation of metabolic enzyme encoding genes during cardiac development and following carvedilol therapy in spontaneously hypertensive rats, CARDIO DRUG, 14(1), 2000, pp. 31-39
Authors:
Bell, SP
Sack, MN
Patel, A
Opie, LH
Yellon, DM
Citation: Sp. Bell et al., Delta opioid receptor stimulation mimics ischemic preconditioning in humanheart muscle, J AM COL C, 36(7), 2000, pp. 2296-2302
Authors:
Mocanu, MM
Baxter, GF
Yue, Y
Critz, SD
Yellon, DM
Citation: Mm. Mocanu et al., The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical, BAS R CARD, 95(6), 2000, pp. 472-478
Authors:
Carroll, R
Yellon, DM
Citation: R. Carroll et Dm. Yellon, Delayed cardioprotection in a human cardiomyocyte-derived cell line: the role of adenosine, p38MAP kinase and mitochondrial K-ATP, BAS R CARD, 95(3), 2000, pp. 243-249
Authors:
Aitchison, KA
Baxter, GF
Awan, MM
Smith, RM
Yellon, DM
Opie, LH
Citation: Ka. Aitchison et al., Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning, BAS R CARD, 95(1), 2000, pp. 1-10
Authors:
Yellon, DM
Baxter, GF
Citation: Dm. Yellon et Gf. Baxter, Sodium-hydrogen exchange in myocardial reperfusion injury, LANCET, 356(9229), 2000, pp. 522-523
Authors:
Jonassen, AK
Brar, BK
Mjos, OD
Sack, MN
Latchman, DS
Yellon, DM
Citation: Ak. Jonassen et al., Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism, J MOL CEL C, 32(5), 2000, pp. 757-764
Authors:
Sumeray, MS
Rees, DD
Yellon, DM
Citation: Ms. Sumeray et al., Infarct size and nitric oxide synthase in murine myocardium, J MOL CEL C, 32(1), 2000, pp. 35-42